Stock listing

Frankfurt:LGDN Ligand Pharmaceuticals Incorporated Aktie

German listing (Frankfurt) of Ligand Pharmaceuticals Incorporated · home listing NASDAQ:LGND

Follow Ligand Pharmaceuticals Incorporated into a list and get an email when it puts out news.

Share price · FWB:LGDN

€260.00 EUR -4.00 (-1.5%)

Close on Nov 20, 2026

Past year +47.5% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€256.00 – €260.00 EURNov 20, 2026
Market cap
€5.18B EURAt the close on Nov 20, 2026 · price × 19.94M shares outstanding
52-week range
€151.34 – €290.42 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€3,940 EURMedian day 0 shares · 36 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Ligand Pharmaceuticals Incorporated logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:LGND · Home$286.85 USD-11.86 (-4.0%)259,769$285.21$291.33$283.01$298.71Close on Nov 20, 2026
Frankfurt:LGDN€260.00 EUR-4.00 (-1.5%)—€256.00€260.00€256.00€264.00Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:LGDN · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€259.81-14.34-5.2%€259.81€259.81€259.810
€274.14+0.382+0.1%€275.11€275.76€273.060
€273.76-1.972-0.7%€273.76€273.76€273.76166
€275.73-2.341-0.8%€273.92€276.33€272.820
€278.07-0.65-0.2%€288.86€290.42€277.040
€278.72-0.97-0.3%€278.38€280.57€278.310
€279.69+5.584+2.0%€281.56€283.84€278.82168
€274.11+3.74+1.4%€276.33€278.78€273.6028
€270.37+2.781+1.0%€270.37€270.37€270.3720
€267.59+0.705+0.3%€268.06€268.06€261.7720
€266.88-6.687-2.4%€271.66€272.34€263.652
€273.57+3.00+1.1%€271.42€273.63€269.280
€270.57+6.108+2.3%€271.26€273.43€270.510
€264.46+6.269+2.4%€261.36€264.50€260.890
€258.19-0.343-0.1%€260.19€262.93€257.580
€258.54+2.053+0.8%€261.79€263.34€258.450
€256.48-7.99-3.0%€260.48€260.62€256.2415
€264.47-6.841-2.5%€266.26€267.25€263.750
€271.31+5.236+2.0%€272.12€272.12€268.0030
€266.08+6.469+2.5%€268.13€268.24€264.900
€259.61+3.306+1.3%€262.23€263.86€259.320
€256.30-2.731-1.1%€257.84€257.84€255.1260
€259.03-7.598-2.8%€259.65€261.28€258.350
€266.63+3.016+1.1%€267.57€269.52€266.430
€263.62-1.799-0.7%€266.26€268.78€262.540
€265.42-2.037-0.8%€265.45€267.34€265.342
€267.45+0.874+0.3%€269.51€274.28€266.580
€266.58-3.726-1.4%€267.23€267.82€266.570
€270.30+9.801+3.8%€270.30€270.30€270.300
€260.50-0.288-0.1%€260.50€260.50€260.500
€260.79+0.615+0.2%€260.79€260.79€260.7926
€260.18+0.947+0.4%€260.18€260.18€260.180
€259.23+9.769+3.9%€259.23€259.23€259.230
€249.46+2.368+1.0%€249.46€249.46€249.460
€247.09+3.213+1.3%€247.09€247.09€247.090
€243.88+7.168+3.0%€244.84€246.47€241.350
€236.71+0.75+0.3%€237.74€237.74€235.290
€235.96+2.377+1.0%€238.07€239.85€234.630
€233.58-11.06-4.5%€237.70€237.75€232.950
€244.64-2.774-1.1%€241.74€248.83€241.1421
€247.42+3.527+1.4%€247.42€247.42€247.4224
€243.89+4.475+1.9%€245.76€247.23€243.250
€239.41+0.882+0.4%€244.55€244.87€237.950
€238.53-5.929-2.4%€242.33€242.35€238.450
€244.46+0.594+0.2%€244.46€244.46€244.460
€243.87+3.99+1.7%€247.02€248.69€240.9782
€239.88-2.189-0.9%€243.83€246.05€238.6520
€242.07-0.205-0.1%€241.95€242.30€241.800
€242.27+9.539+4.1%€242.27€242.27€242.2728
€232.73-5.598-2.3%€240.79€241.09€232.0020
€238.33-1.954-0.8%€239.80€239.89€238.3226
€240.28+3.034+1.3%€245.31€248.19€239.9339
€237.25-2.32-1.0%€238.73€239.57€233.770
€239.57+1.614+0.7%€239.67€239.72€238.4320
€237.96-3.228-1.3%€239.08€239.97€237.890
€241.18-4.837-2.0%€242.20€242.20€238.7145
€246.02+2.258+0.9%€246.27€248.22€242.050
Ticker
Frankfurt:LGDN
Asset type
Stock
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Ligand Pharmaceuticals (NASDAQ:LGND) Q3 2026 Earnings Call

    Thu, Oct 29, 2026 · 8:30 AM ET

    Watch Transcript
  • Ligand Pharmaceuticals (NASDAQ:LGND) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 8:30 AM ET

    Watch Transcript
  • Ligand Pharmaceuticals (NASDAQ:LGND) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

All Ligand Pharmaceuticals Incorporated news

Financings

  • 0.0% convertible senior notes due 2031

    Jun 23, 2026

    Made bigger: US$625M

    Use of proceeds: Convertible note hedge cost, repurchase of about $60 million of common stock, and general corporate purposes including investing in complementary businesses

    Made bigger Jun 23, 2026

  • Convertible senior notes due 2031

    Jun 22, 2026

    Announced: US$550M

    Use of proceeds: Convertible note hedge costs, up to $75 million of share repurchases, and general corporate purposes including investing in complementary businesses

    Announced Jun 22, 2026

  • 0.75% convertible senior notes due 2030

    Aug 14, 2025

    Closed: US$460M raised

    Use of proceeds: Remaining net proceeds for general corporate purposes

    Announced Aug 11, 2025 · Closed Aug 14, 2025

Read by 6ix AI from the company's releases

Decks

Ligand Pharmaceuticals Incorporated on 6ix

News releases
22 in the last 12 months · 182 in all · newest Oct 29, 2026 · oldest 2019
Calls
24 calls with a replay · 24 with a transcript · latest Oct 29, 2026
Decks
54 decks · latest Oct 29, 2026

Where Ligand Pharmaceuticals Incorporated is listed

ListingExchangeCountryCurrency
NASDAQ:LGND · Home listingNASDAQUnited StatesUSD
gettex:LGDNgettexGermanyEUR
Tradegate:LGDNTradegateGermanyEUR
Lang & Schwarz:A1C9RNLang & SchwarzGermanyEUR
LS Exchange:A1C9RNLS ExchangeGermanyEUR
BOATS:LGNDBOATSUnited StatesUSD
Frankfurt:LGDN · This pageFrankfurtGermanyEUR
Stuttgart:LGDNStuttgartGermanyEUR
BX Swiss:LGDNBX SwissSwitzerlandCHF
Dusseldorf:LGDNDusseldorfGermanyEUR
Munich:LGDNMunichGermanyEUR

Log in to ask 6ix AI your own questions about Ligand Pharmaceuticals Incorporated.